Moderna's stock has seen significant movement, with reports of both gains and losses on different days. The stock has been reported to be up by varying percentages, including 14% and 6% on certain days, and is also said to be up 94% for the year. The performance of Moderna's stock in relation to other vaccine stocks, such as Pfizer, is unclear, with conflicting reports on whether it is outperforming them.